Castle Biosciences to Present at Upcoming Investor Conferences

Rhea-AI Summary

Castle Biosciences, Inc. (Nasdaq: CSTL) announced that its CEO, Derek Maetzold, and CFO, Frank Stokes, will present at the Virtual Wells Fargo Healthcare Conference on September 9, 2021, and the Baird Global Healthcare Conference on September 15, 2021. Live audio webcasts will be accessible on the company’s website, with replays available for two weeks after the events. Additionally, the company will hold one-on-one meetings during the Lake Street Capital Markets Best Ideas Growth Conference on September 14, 2021.

FRIENDSWOOD, Texas--(BUSINESS WIRE)-- Castle Biosciences, Inc. (Nasdaq: CSTL), a dermatologic diagnostics company providing personalized genomic information to inform treatment decisions, today announced that Derek Maetzold, president and chief executive officer, and Frank Stokes, chief financial officer, are scheduled to present a company overview at the following upcoming investor conferences:

• 2021 Virtual Wells Fargo Healthcare Conference on Sept. 9, 2021, at 9:20 a.m. Eastern time.
• Baird 2021 Global Healthcare Conference on Sept. 15, 2021, at 9:40 a.m. Eastern time.

Live audio webcasts of the company’s presentations will be available by visiting Castle Biosciences’ website at https://ir.castlebiosciences.com/events-presentations/default.aspx. Replays of the webcasts will be available for two weeks following the conclusion of the live broadcasts.

Castle will also be available on Sept. 14, 2021, for one-on-one investor meetings during the Lake Street Capital Markets 5th Annual Best Ideas Growth (BIG5) Conference. Meetings may be requested exclusively through Lake Street Capital Markets.

About Castle Biosciences

Castle Biosciences (Nasdaq: CSTL) is a commercial-stage dermatologic diagnostics company focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The Company currently offers tests for patients with cutaneous melanoma (DecisionDx^®-Melanoma, DecisionDx^® -CMSeq), cutaneous squamous cell carcinoma (DecisionDx^®-SCC), suspicious pigmented lesions (myPath® Melanoma, DecisionDx^® DiffDx™-Melanoma,) and uveal melanoma (DecisionDx^®-UM, DecisionDx^®-PRAME and DecisionDx^®-UMSeq). For more information about Castle’s gene expression profile tests, visit www.CastleTestInfo.com.

Castle also has active research and development programs for tests in other dermatologic diseases with high clinical need, including its test in development to predict systemic therapy response in patients with moderate to severe psoriasis, atopic dermatitis and related conditions. Castle Biosciences is based in Friendswood, Texas (Houston), and has laboratory operations in Phoenix.

For more information, visit www.CastleBiosciences.com.

DecisionDx-Melanoma, DecisionDx-CMSeq, DecisionDx-SCC, myPath Melanoma, DecisionDx DiffDx-Melanoma, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UMSeq are trademarks of Castle Biosciences, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210826005013/en/

Investor Contact:

Camilla Zuckero

832-835-5158

czuckero@castlebiosciences.com

Media Contact:

Allison Marshall

amarshall@castlebiosciences.com

Source: Castle Biosciences, Inc.

FAQ

When will Castle Biosciences present at the Wells Fargo Healthcare Conference?

Castle Biosciences will present at the Wells Fargo Healthcare Conference on September 9, 2021, at 9:20 a.m. Eastern time.

What is the date for Castle Biosciences' presentation at the Baird Global Healthcare Conference?

Castle Biosciences is scheduled to present at the Baird Global Healthcare Conference on September 15, 2021, at 9:40 a.m. Eastern time.

Where can I watch the live webcasts of Castle Biosciences' presentations?

Live audio webcasts of Castle Biosciences' presentations can be accessed on their website.

What other event will Castle Biosciences participate in on September 14, 2021?

Castle Biosciences will hold one-on-one investor meetings during the Lake Street Capital Markets 5th Annual Best Ideas Growth Conference on September 14, 2021.

What services does Castle Biosciences provide?

Castle Biosciences offers personalized genomic information for dermatologic diagnostics, helping physicians make informed treatment decisions.